Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 73 results for "cipla"

Cipla gains 2% on USFDA approval for asthma drug
Money Control

USFDA gives final approval to Cipla#39;s anti-asthma product

In a BSE filing today, Cipla said "it has received final approval for its abbreviated new drug application (ANDA) for Budesonide Inhalation Suspension, 0.25mg/2mL, 0.5mg/2mL, and 1mg/2mL from the United States Food and Drug Administration (USFDA)". Money Control, 1 day ago

48 images for cipla

Business Standard, 1 day ago
Business Standard, 1 day ago
Business Standard, 1 week ago
Sify, 1 day ago
Business Standard, 1 day ago
Money Control, 1 day ago
Money Control, 1 day ago
Money Control, 2 weeks ago
Money Control, 3 weeks ago
Money Control, 1 week ago
Business Standard

YES Bank, IndusInd to join BSE Sensex; Lupin, Cipla out

YES Bank has gained nearly a third so far this year, while IndusInd has added more than 45 per cent Press Trust of India Last Updated at November 17, 2017 21:11 IST Private sector lenders -- IndusInd Bank and Yes Bank -- will make an entry in the BSE's ...
 Business Standard1 day ago Yes Bank, IndusInd to join India's BSE Sensex index; Lupin, Cipla dropped  Sify1 day ago
Money Control

Market Update: Cipla gains over 3%; Axis Bank hits 52-week high, Bharti Airtel most active

CNX Pharma gained close to 1 percent led by Cipla, Sun Pharma and Aurobindo Pharma while Bharti Airtel, Axis Bank, Lupin, Yes Bank and Reliance Industries were the most active stocks.
 Money Control1 week ago Cipla tanks 8% despite better Q2 nos; Lupin post warning letter drags Nifty Pharma 5%  Money Control1 week ago Market update: Bharti Airtel, Cipla hit new 52-week high; ICICI, SBI, Sun Pharma most active  Money Control2 weeks ago R&D growth in pharma firms like Cipla, Dr Reddy's outpaces revenue growth  Business Standard1 month ago
Business Standard

Market Update: Axis Bank top gainer, TCS hits new 52-week high; SBI most active

From the Nifty, the stocks that gained the most were Cipla which jumped over 4 percent while Tech Mahindra was up 2.82 percent. Sun Pharma, Axis Bank and Bharti Infratel were the other top Nifty gainers.
 Money Control1 week ago Cipla hits 52-week high ahead of Q2 results  Business Standard1 week ago Market update: Axis Bank, HCL Tech top Nifty gainers; RComm zooms over 11%  Money Control2 weeks ago

Cipla plans to enter China#39;s branded respiratory business in coming quarters

The company plans to either acquire a company in China or collaborate with a local partner for this.
 Money Control1 week ago
Business Standard

Cipla net up 19 per cent in Q2

Pharma-cum-biotech firm Cipla on Tuesday reported Rs 423 crore consolidated net profit for the second quarter of 2017-18, registering 19 per cent annual growth from Rs 354 crore in the same period last year.Sequentially, however, the net profit for Q2 is ...
 Prokerala1 week ago Cipla beats estimates, records Q2 net profit at Rs 434 cr  Business Standard1 week ago

Cipla second-quarter profit rises 19 percent

Reuters Staff 1 Min Read (Reuters) - Cipla Ltd, India’s second largest drugmaker by market capitalisation, posted a 19 percent rise in quarterly profit, slightly above analysts’ estimate. FILE PHOTO: Employees and security staff work at the ...
 Reuters1 week ago Cipla second-quarter profit up 19 percent on higher domestic sales  Reuters1 week ago
Sify

Prescient messages about Indian companies circulate in WhatsApp groups

MUMBAI: Three days before Dr. Reddy's Laboratories Ltd announced quarterly results this summer, a message circulated on a private WhatsApp group saying the Indian drugmaker would not post good numbers. Dr. Reddy's was going to report a loss, according to the ...
 Sify2 days ago EXCLUSIVE-Prescient messages about Indian companies circulate in WhatsApp groups  Sify2 days ago

Morning News Call - India, November 7

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_11072017.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ ...
 Sify1 week ago REFILE-Morning News Call - India, November 7  Sify1 week ago
Sify

Opening Bell: Sensex down 29 points, large concerns as Oil & Gas dips over 1 percent

The opening bell for the Indian benchmarks saw a steep decline. By 10:00 AM, benchmark indices such as the Sensex were down marginally by 29 points, while NSE Nifty was trading 6.70 points in the South. The concerns on rising dollar prices has been emerging.
 Sify1 week ago Closing Bell: Healthcare slips, Rupee plunges and Sensex crashes 360 points  Sify1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less